Is this product CE certified?

Yes, the product has obtained the CE certificate.

Silent 50lpm Piston Air Compressor for 3liter Oxygen Concentrator

Name: Silent 50lpm Piston Air Compressor for 3liter Oxygen Concentrator
Brand: Sinc Gleeman Medical Technology(Changzhou) Co.,Ltd.
SKU: 1955890615

Jiangsu, ChinaSinc Gleeman Medical Technology(Changzhou) Co.,Ltd.

US$48.00

1-499 Pieces

US$46.00

500-999 Pieces

US$44.00

1,000-4,999 Pieces

US$40.00

5,000-9,999 Pieces

US$35.00

10,000+ Pieces

Sample price:US$48.00/piece.Request sample

Product profile

Customization

Available

After-sales Service

on Line Support and Free Spare Parts

Warranty

Two Years

Model NO.

GLE210B

Lubrication Style

Oil-free

Cooling System

Air Cooling

Cylinder Arrangement

Duplex Arrangement

Structure Type

Semi-Closed Type

Compress Level

Double-Stage

Power Source

AC Power

Brand Name

OEM

Voltage

According to Your Requirement

Core Components

Motor

Capacity

50 L/Min @ 1.4 Bar

Configuration

Portable

Wokr Pressure

1.4bar,2bar or According to Customer Requirement

Certificate

Transport Package

4 PCS / Carton Case, Carton Case Size Is: L40*W

Specification

176*95*143 mm

Origin

China

HS Code

8414804990

Production Capacity

200000pieces/Year

Key features

High Efficiency Output: Rated air flow rate >=50 L/min @ 1.4 bar with double-stage compression.

Compact Portable Design: Lightweight 4.0 kg, dimensions 176*95*143 mm, ideal for portable use.

Flexible Voltage Options: Supports AC220V 50Hz and 110V 60Hz to meet global power requirements.

CE Certified Quality: Product holds CE certificate ensuring safety and compliance standards.

Comprehensive Warranty: Two-year warranty coverage with online support and free spare parts.

Company profile

Sinc Gleeman Medical Technology(Changzhou) Co.,Ltd.

Jiangsu, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2020-06-11Nearest Port: ShanghaiAverage Response Time: ≤2.85hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, EXW, CIF, DDP

AI-Powered supplier vetting

SummarySinc Gleeman Medical Technology (Changzhou) Co., Ltd. is identified as both a trading company and manufacturer/factory in China. The supplier reports substantial manufacturing infrastructure, including over 600 employees, a 61,000-square-meter facility, more than 10 production lines, vertical integration, and stated annual capacity of 4,000,000 oil-free air pumps. It exports to multiple regions and holds ISO 9001 and ISO 14001 certifications. The supplier also states that it supports OEM/ODM partnerships. However, many operational, R&D, service, traceability, and contract-related fields remain unknown. An SGS audit is documented with a validity period from June 18, 2024 to June 17, 2025, but the provided audit result code is not interpretable as a substantive performance conclusion.

Supplier typeThe supplier is explicitly classified as both a Trading Company and Manufacturer/Factory. Its stated die-casting, motor production, CNC finishing, automatic assembly, and vertically integrated supply-chain operations support the presence of manufacturing capability rather than trading-only activity.

CertificationsThe supplier reports ISO 14001 and ISO 9001 certification. An SGS audit is also documented, with a stated validity period from 2024-06-18 to 2025-06-17; however, the supplied audit result value is not sufficiently explained to assess the audit outcome.

Production capacityProduction capability is supported by more than 10 production lines, over 600 employees, a 61,000-square-meter factory, full production facilities and testing instruments, vertical integration, and stated annual capacity of 4,000,000 oil-free air pumps. The supplier also reports 3,000,000 oxygen concentrator compressor pieces in annual output information.

Customization capabilityThe supplier explicitly states that it works with global intelligent product brand owners, retailers, and distributors to establish OEM/ODM partnerships. However, the dedicated OEM capability, ODM service availability, and related R&D service fields are otherwise marked unknown, so the evidence confirms stated partnership intent but not the full scope of customization execution.